Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.
2.

The safety evaluation of fluvastatin, an HMG-CoA reductase inhibitor, in beagle dogs and rhesus monkeys.

Hartman HA, Myers LA, Evans M, Robison RL, Engstrom RG, Tse FL.

Fundam Appl Toxicol. 1996 Jan;29(1):48-62.

PMID:
8838639
4.

The HMG-CoA reductase inhibitor fluvastatin inhibits insect juvenile hormone biosynthesis.

Debernard S, Rossignol F, Couillaud F.

Gen Comp Endocrinol. 1994 Jul;95(1):92-8.

PMID:
7926659
5.

HMG-CoA reductase inhibitor fluvastatin prevents angiotensin II-induced cardiac hypertrophy via Rho kinase and inhibition of cyclin D1.

Morikawa-Futamatsu K, Adachi S, Maejima Y, Tamamori-Adachi M, Suzuki J, Kitajima S, Ito H, Isobe M.

Life Sci. 2006 Aug 29;79(14):1380-90. Epub 2006 Apr 25.

PMID:
16712874
6.

Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: dose-response, and biochemical and pharamacokinetic parameters.

Luebker DJ, York RG, Hansen KJ, Moore JA, Butenhoff JL.

Toxicology. 2005 Nov 5;215(1-2):149-69. Epub 2005 Aug 29.

PMID:
16129535
7.

Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro.

Flint OP, Masters BA, Gregg RE, Durham SK.

Toxicol Appl Pharmacol. 1997 Jul;145(1):91-8.

PMID:
9221828
8.
10.

Reproductive toxicity of exemestane, an antitumoral aromatase inactivator, in rats and rabbits.

Beltrame D, di Salle E, Giavini E, Gunnarsson K, Brughera M.

Reprod Toxicol. 2001 Mar-Apr;15(2):195-213. Erratum in: Reprod Toxicol 2001 Sep-Oct;15(5):601-2.

PMID:
11297878
11.

Fluvastatin: a review of its pharmacology and use in the management of hypercholesterolaemia.

Plosker GL, Wagstaff AJ.

Drugs. 1996 Mar;51(3):433-59. Review.

PMID:
8882381
12.
13.

Cholesterol biosynthesis regulation and protein changes in rat liver following treatment with fluvastatin.

Steiner S, Gatlin CL, Lennon JJ, McGrath AM, Seonarain MD, Makusky AJ, Aponte AM, Esquer-Blasco R, Anderson NL.

Toxicol Lett. 2001 Mar 31;120(1-3):369-77.

PMID:
11323196
14.

Fluvastatin induces apoptosis in rat neonatal cardiac myocytes: a possible mechanism of statin-attenuated cardiac hypertrophy.

Ogata Y, Takahashi M, Takeuchi K, Ueno S, Mano H, Ookawara S, Kobayashi E, Ikeda U, Shimada K.

J Cardiovasc Pharmacol. 2002 Dec;40(6):907-15.

PMID:
12451324
15.

[Fluvastatin in the treatment of hyperlipoproteinemia, initial experience].

Ceska R.

Vnitr Lek. 1996 Aug;42(8):533-6. Czech.

PMID:
8967021
16.
17.

Pre- and postnatal development studies of lasofoxifene, a selective estrogen receptor modulator (SERM), in Sprague-Dawley rats.

Weisenburger WP, Hagler AR, Tassinari MS.

Birth Defects Res B Dev Reprod Toxicol. 2004 Jun;71(3):171-84.

PMID:
15282738
19.

Fluvastatin inhibits matrix metalloproteinase-1 expression in human vascular endothelial cells.

Ikeda U, Shimpo M, Ohki R, Inaba H, Takahashi M, Yamamoto K, Shimada K.

Hypertension. 2000 Sep;36(3):325-9.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk